NCT05683548 2025-02-17
RCAP
Replicor Inc.
No longer available
Clinical Trials
4 trialsNCT03887702 2024-05-20
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors
SWOG Cancer Research Network
Phase 3 Terminated
NCT02186574 2019-12-12
Tenofovir to Prevent HBV Reactivation
University Health Network, Toronto
Phase 3 Unknown
NCT01872988 2014-09-04
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma
Taichung Veterans General Hospital
Phase 3 Terminated